Geoff Pardo and three successful medtech CEOs who exited their companies through a different pathway— M&A, IPO, and SPAC—discuss the pros and cons of each. While market volatility is a given, Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical; Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth; and Leslie Trigg, CEO, Outset Medical agreed that successful CEOs keep their focus on delivering returns for their investors—whether private or public. If your company is solving a really important problem and is creating value for patients, you’ll ultimately succeed, Shook said. From there, Trigg pointed out, exit vehicles are simply different modes of transportation to the same place. 

GUESTS:
Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical 
Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth 
Leslie Trigg, CEO, Outset Medical, Inc. 

HOST:  
Geoff Pardo, General Partner, Gilde Healthcare; Host, Medtech Talk podcast  

LINKS:
Cambridge Healthtech Institute
Medtech Talk
Gilde Healthcare
OrangeTwist
Outset Medical